OCUL/EYPT - Only other bioerodible insert that I am aware of in preclinical experiments is Nicox/Re-Vana. Eyepoint/Nicox collaboration dropped last year. EYPT focused on commercialization of Dexycu and Yutig for cataract surgery and posterior segment uveitis respectively.
Market Data 
Markets 
AI
